September 21. Alzheimer’s Disease International’s 2026 report examines recruitment, ethics, and representation in dementia clinical trials. It asks how research can become more inclusive and accessible as new diagnostics and treatments develop. Why it belongs here: The report helps OBCA connect scientific progress with the experiences of people and families involved in research.

Original source: Alzheimer’s Disease International, full report